Comments on NHSA's 2019 National Reimbursement Drug List Adjustment Work Plan

2019-03-26 | Beijing, Shanghai

The European Chamber calls for the Chinese medical regulators to establish a dynamic mechanism to adjust the National Reimbursement Drug List, take the Provincial Reimbursement Drug List into consideration while updating the national list and grant better access to products for rare disease. The Chamber also recommend the NHSA to learn best practice from Europe.